Biotech Investor Adds $3M to Krystal Biotech

Deal Summary

A biotech investor has committed an additional $3 million to Krystal Biotech, boosting its capital as the company reports $389 million in revenue for 2025. The fresh funding is expected to support further development and growth initiatives.